CID 3041833

10,11-dihydro-8-(ethylsulfonyl)-n,n,5-trimethyl-5h-dibenz(b,f)azepine-10-ethanamine

Structural Information

Molecular Formula
C21H28N2O2S
SMILES
CCS(=O)(=O)C1=CC2=C(C=C1)N(C3=CC=CC=C3CC2CCN(C)C)C
InChI
InChI=1S/C21H28N2O2S/c1-5-26(24,25)18-10-11-21-19(15-18)16(12-13-22(2)3)14-17-8-6-7-9-20(17)23(21)4/h6-11,15-16H,5,12-14H2,1-4H3
InChIKey
MOYNETOGAMLCBJ-UHFFFAOYSA-N
Compound name
2-(3-ethylsulfonyl-11-methyl-5,6-dihydrobenzo[b][1]benzazepin-5-yl)-N,N-dimethylethanamine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

372.18716 Da
Monoisotopic Mass

3.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 373.194436 188.8
[M+Na]+ 395.176378 194.6
[M-H]- 371.179884 194.8
[M+NH4]+ 390.220983 202.2
[M+K]+ 411.150318 195.0
[M+H-H2O]+ 355.184420 182.0
[M+HCOO]- 417.185361 201.3
[M+CH3COO]- 431.201011 224.0
[M+Na-2H]- 393.161826 191.1
[M]+ 372.18661142 191.3
[M]- 372.18770858 191.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.